Q3 FY2013 · ended Sep 30, 2013 · Revenue $6.04M, -39.0% YoY · Filed Nov 14, 2013
Tanke Biosciences Corp (TNBI) files with the SEC under industry code 2040, Grain Mill Products. In Q3 of fiscal 2013, the quarter ended Sep 30, 2013, it reported revenue of $6.0 million and a net loss of $302,084. Free cash flow was $538,076. As of Sep 30, 2013 it held $5.1 million in cash and investments and $1.9 million in total debt.
Revenue
$6.04M
-39.0% vs year-ago quarter
Net income
$-302,084
-131.2% vs year-ago quarter
Operating cash flow
$1.61M
+3.8% vs year-ago quarter
Free cash flow
$538,076
-52.8% vs year-ago quarter
EPS
$0.07
+250.0% vs prior quarter
Dividend per share
None
Shares outstanding
13.32M
+0.0% vs year-ago quarter
Net cash
$3.18M
Q3 FY2013
Operating margin
-0.2%
TTM
Company profile
- Industry
- Grain Mill Products (SIC 2040)
- Listed as
- TNBI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Pearl River New City Guangzhou, China
- SEC CIK
- 1452011
- Former names
- GREYHOUND COMMISSARY, INC. (until Feb 3, 2011)
Other Grain Mill Products companies
- General Mills Inc GIS
- Ingredion Inc INGR
- Post Holdings, Inc. POST
- Freshpet, Inc. FRPT
- Forafric Global PLC AFRI
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2013 Sep 30, 2013 |
Q2 FY2013 Jun 30, 2013 |
Q1 FY2013 Mar 31, 2013 |
Q4 FY2012 Dec 31, 2012 |
Q3 FY2012 Sep 30, 2012 |
|---|---|---|---|---|---|
| Revenue | $6.0M | $5.6M | $4.7M | $6.7M | $9.9M |
| Operating income | -$530,338 | $149,690 | -$39,893 | $363,273 | $2.2M |
| Net income | -$302,084 | $118,164 | -$676,329 | -$780,316 | $968,632 |
| Diluted EPS | — | — | — | — | $0.07 |
| Operating cash flow | $1.6M | -$134,582 | -$101,190 | -$5.0M | $1.6M |
| Free cash flow | $538,076 | -$748,078 | -$847,223 | -$5.1M | $1.1M |
| Total assets | $28.8M | $29.5M | $28.7M | $28.8M | $28.8M |
| Total liabilities | $13.1M | $13.6M | $13.3M | $12.9M | $12.3M |
| Stockholders' equity | $15.6M | $15.7M | $15.2M | $15.8M | $16.5M |
| Cash and investments | $5.1M | $4.7M | $5.6M | $6.2M | $11.0M |
| Total debt | $1.9M | $2.1M | $2.2M | $2.1M | $2.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Dec 26, 2013 | Dec 19, 2013 |
| 8-K | Current report | Nov 22, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Nov 14, 2013 | Sep 30, 2013 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2013 | Sep 30, 2013 |
| 8-K |
Current report
Material agreement
|
Aug 29, 2013 | Aug 23, 2013 |
| 10-Q | Quarterly report | Aug 14, 2013 | Jun 30, 2013 |
All 127 Tanke Biosciences Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.